Sandbox Reserved 1760

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (02:49, 13 December 2022) (edit) (undo)
 
(3 intermediate revisions not shown.)
Line 6: Line 6:
== Function of your protein ==
== Function of your protein ==
-
The protein Ornithine Aminotransferase (OAT), in humans (hOAT), is an enzyme that catalyzes the the transfer of an amino group from L-ornithine(L-Orn) to α-ketoglutarate (α-KG). Its ligand, pyridoxal-5'-phosphate (PLP), is a cofactor of this reaction. An amino group from L-Orn is transferred to PLP which converts it to pyridoxamine phosphate (PMP) and L-Orn is converted to L-glutamate-γ-semialdehyde. When the amino group of PMP is transferred to the α-KG, it forms glutamate and regenerates PLP.
+
The protein Ornithine Aminotransferase (OAT), in humans (hOAT), is an enzyme that catalyzes the the transfer of an amino group from L-ornithine(L-Orn) to α-ketoglutarate (α-KG). Its ligand, pyridoxal-5'-phosphate (<scene name='93/934004/Plp/1'>PLP</scene>), is a cofactor of this reaction. An amino group from L-Orn is transferred to PLP which converts it to pyridoxamine phosphate (PMP) and L-Orn is converted to L-glutamate-γ-semialdehyde. When the amino group of PMP is transferred to the α-KG, it forms glutamate and regenerates PLP.
== Biological relevance and broader implications ==
== Biological relevance and broader implications ==
hOAT is found in most tissues in the body but predominates in the liver and kidney. There is a need to study the enzyme hOAT because the overexpression of this protein aids the proliferation of cancer cells, specifically Hepatocellular carcinoma (HCC), a common form of liver cancer. hOAT has been a target for mechanism-based inactivators (MBIs) in ongoing drug design efforts. HCC is normally diagnosed at advanced stages where the tumors tend to be resistant to radiotherapy and chemotherapy, making this type of cancer difficult to treat.
hOAT is found in most tissues in the body but predominates in the liver and kidney. There is a need to study the enzyme hOAT because the overexpression of this protein aids the proliferation of cancer cells, specifically Hepatocellular carcinoma (HCC), a common form of liver cancer. hOAT has been a target for mechanism-based inactivators (MBIs) in ongoing drug design efforts. HCC is normally diagnosed at advanced stages where the tumors tend to be resistant to radiotherapy and chemotherapy, making this type of cancer difficult to treat.
Line 13: Line 13:
Amino Acids in the <scene name='93/934004/Plp_binding_site/6'>PLP binding site</scene> are Lys 292, Asp 263, Arg 180. They are essential to the active site by providing certain <scene name='93/934004/Plp_ligand/2'>interactions with PLP</scene>. PLP is covalently bonded to the amino acid lysine. The nitrogen in the ring of PLP interacts with the negatively charged oxygen in the aspartate side chain. The phosphate group interacts with the positively charged nitrogen of the arginine side chain. Another interaction provided in this active site but not apart of the catalytic triad is the amino acid phenylalanine 177, there is a pi stacking interaction between its ring and the ring of the PLP. Other amino acids that have served importance to PLP and binding the substrate L-Orn appear to be <scene name='93/934004/Ph_sites/1'>Arg 413 and Glu 235</scene>. At a pH of 6.0 a salt bridge is formed between Arg 413 and Glu 235, these amino acids also regulate the width of the active site and establish the size of the channel that the substrate passes through. At a pH of 7.8 conformational changes of Arg 413 and Glu 235 causes the distance between the side chains to increase therefore that restriction of the active-site isn't as prevalent. Another conformational change occurs from a pH of 6.0 to 7.8 with Arg 180. At a pH of 6.0 Arg 180 is able to interact with PLP as previously described but that interaction is disrupted at a pH of 7.8. These conformational changes alter the binding affinity and contribute to a slower catalytic rate due to the decrease in interactions with less acidic conditions.
Amino Acids in the <scene name='93/934004/Plp_binding_site/6'>PLP binding site</scene> are Lys 292, Asp 263, Arg 180. They are essential to the active site by providing certain <scene name='93/934004/Plp_ligand/2'>interactions with PLP</scene>. PLP is covalently bonded to the amino acid lysine. The nitrogen in the ring of PLP interacts with the negatively charged oxygen in the aspartate side chain. The phosphate group interacts with the positively charged nitrogen of the arginine side chain. Another interaction provided in this active site but not apart of the catalytic triad is the amino acid phenylalanine 177, there is a pi stacking interaction between its ring and the ring of the PLP. Other amino acids that have served importance to PLP and binding the substrate L-Orn appear to be <scene name='93/934004/Ph_sites/1'>Arg 413 and Glu 235</scene>. At a pH of 6.0 a salt bridge is formed between Arg 413 and Glu 235, these amino acids also regulate the width of the active site and establish the size of the channel that the substrate passes through. At a pH of 7.8 conformational changes of Arg 413 and Glu 235 causes the distance between the side chains to increase therefore that restriction of the active-site isn't as prevalent. Another conformational change occurs from a pH of 6.0 to 7.8 with Arg 180. At a pH of 6.0 Arg 180 is able to interact with PLP as previously described but that interaction is disrupted at a pH of 7.8. These conformational changes alter the binding affinity and contribute to a slower catalytic rate due to the decrease in interactions with less acidic conditions.
== Structural highlights ==
== Structural highlights ==
-
hOAT is a protein with <scene name='93/934004/Secondary_structure/2'>secondary</scene> structures consisting of alpha helices, parallel and antiparallel beta sheets, and random coil. It's a polymer with a <scene name='93/934004/Quaternary/1'>globular structure</scene> that has three subunits held together by non-covalent interactions like hydrogen bonds and salt bridges between the side chains of amino acids.
+
hOAT is a protein with <scene name='93/934004/Secondary_structure/2'>secondary</scene> structures consisting of alpha helices, parallel and antiparallel beta sheets, and random coil. It's a polymer with a <scene name='93/934004/Quaternary/1'>globular structure</scene> that has three subunits held together by non-covalent interactions like hydrogen bonds and salt bridges between the side chains of amino acids. Two of the subunits are bound and fit more closely together leaving a pocket/space between the two subunits shown in purple and orange and the subunit shown in green. Since there is an active within each subunit, the observed conformational changes seen in Arg 180, Arg 413, and Glu 235 that cause a decrease in reaction rate at a pH of 6.0 could also be contributed by the protonation state of other active sites within hOAT that don't induce conformational changes.
The <scene name='93/934004/Binding_pocket/3'>binding pocket</scene> of PLP are semi-exposed to the "outside world" but also slightly hidden into the protein. Having binding pockets exposed slightly can help other competitive substrates bind to this active site and inhibit the enzyme if necessary.
The <scene name='93/934004/Binding_pocket/3'>binding pocket</scene> of PLP are semi-exposed to the "outside world" but also slightly hidden into the protein. Having binding pockets exposed slightly can help other competitive substrates bind to this active site and inhibit the enzyme if necessary.
The ligand PLP has a phosphate group that is surrounded by other polar amino acids but the rest of the molecule, the carbons are surrounded by other non-polar amino acids to satisfy the needs of the <scene name='93/934004/Polar_non-polar_with_plp/1'>ligand and active site</scene>. PLP would not be very stable if the polar/hydrophilic portions of the molecule were trying to interact with all surrounding non-polar/hydrophobic amino acids. This allows interactions such as hydrogen bonding and pi-stacking to stabilize and bind the ligand in the active site.
The ligand PLP has a phosphate group that is surrounded by other polar amino acids but the rest of the molecule, the carbons are surrounded by other non-polar amino acids to satisfy the needs of the <scene name='93/934004/Polar_non-polar_with_plp/1'>ligand and active site</scene>. PLP would not be very stable if the polar/hydrophilic portions of the molecule were trying to interact with all surrounding non-polar/hydrophobic amino acids. This allows interactions such as hydrogen bonding and pi-stacking to stabilize and bind the ligand in the active site.
</StructureSection>
</StructureSection>
== References ==
== References ==
-
<references/>
+
Butrin A, Butrin A, Wawrzak Z, Moran GR, Liu D. Determination of the pH dependence, substrate specificity, and turnovers of alternative substrates for human ornithine aminotransferase. J Biol Chem. 2022 Jun;298(6):101969. doi: 10.1016/j.jbc.2022.101969. Epub 2022 Apr 20. PMID: 35460691; PMCID: PMC9136103.

Current revision

This Sandbox is Reserved from November 4, 2022 through January 1, 2023 for use in the course CHEM 351 Biochemistry taught by Bonnie Hall at the Grand View University, Des Moines, USA. This reservation includes Sandbox Reserved 1755 through Sandbox Reserved 1764.
To get started:
  • Click the edit this page tab at the top. Click on Show preview and then Save the page after each step, then edit it again.
  • show the Scene authoring tools, create a molecular scene, and save it. Copy the green link into the page.
  • Add a description of your scene. Use the buttons above the wikitext box for bold, italics, links, headlines, etc.

More help: Help:Editing

Human Ornithine Aminotransferase

Caption for this structure

Drag the structure with the mouse to rotate

References

Butrin A, Butrin A, Wawrzak Z, Moran GR, Liu D. Determination of the pH dependence, substrate specificity, and turnovers of alternative substrates for human ornithine aminotransferase. J Biol Chem. 2022 Jun;298(6):101969. doi: 10.1016/j.jbc.2022.101969. Epub 2022 Apr 20. PMID: 35460691; PMCID: PMC9136103.

Personal tools